Episode Details

Back to Episodes
What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul

What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul

Published 5 years, 3 months ago
Description
This week's episode focuses on new hope for people with diabetes. Brad Paddock, CEO of CeQur, explains how its "wearable pen" can deliver insulin in a better way while Sean Salmon, head of Medtronic's diabetes business, reviews that company's growing portfolio. He also gives insights on its intriguing partnership with the private equity group, Blackstone. Chris Newmarker, executive editor of life sciences, drops a weighty Newmarker's Newmakers featuring stories from Hillrom, Baxter, NeuroMetrix, Philips, Medtronic and BD. Subscribe to this podcast on all major podcast apps.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us